Trial reportBMC research notes2025
Clinical observation of early postoperative wear of balafilcon A and innovative first-generation samfilcon a silicone hydrogel bandage contact lenses after SMILE surgery.
Trial report in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesOur objective was to compare the efficacy of two different silicone hydrogel bandage contact lenses on ocular surface after small incision lenticule extraction (SMILE) surgery. In this prospective, double-masked, contralateral, comparative clinical study, 25 patients who received SMILE in both eyes wore two different silicone hydrogel bandage contact lenses (BCLs): balafilcon A in one eye and samfilcon A in the other randomly. The scores of BCL deposits on the lens surface and the level of ocular discomfort were assessed on the first day after surgery. Ocular Surface Disease Index (OSDI), the 5-Item Dry Eye Questionnaire (DEQ-5), corneal sensitivity, ocular surface parameters and tear inflammatory mediators were assessed preoperatively and 1 day, 1 week, and 1 month postoperatively. DATA DESCRIPTION: There were no significant differences in subjective symptoms scores, OSDI scores, DEQ-5 scores, corneal sensitivity, ocular surface parameters or tear inflammatory mediators between the BCLs postoperatively (p > 0.05). Both samfilcon A and balafilcon A contact lenses are safe with equivalent efficacy on ocular surface after SMILE. The scores of BCL deposits were lower in the samfilcon A group than that in the balafilcon A group after SMILE (samfilcon A vs. balafilcon A: 1.28 ± 0.68 vs. 2.56 ± 0.82, P = 0.045).
trial registrationChinese Clinical Trial Registry: ChiCTR2400083482 (26 April 2024).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.